Ra Medical Systems, Inc. (RMED): Price and Financial Metrics
RMED Price/Volume Stats
Current price | $0.59 | 52-week high | $11.14 |
Prev. close | $0.54 | 52-week low | $0.52 |
Day low | $0.52 | Volume | 77,500 |
Day high | $0.59 | Avg. volume | 197,480 |
50-day MA | $0.81 | Dividend yield | N/A |
200-day MA | $2.21 | Market Cap | 3.19M |
RMED Stock Price Chart Interactive Chart >
Ra Medical Systems, Inc. (RMED) Company Bio
RA Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is based in Carlsbad, California.
Latest RMED News From Around the Web
Below are the latest news stories about RA MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate RMED as an investment opportunity.
Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division/ Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricular ablation procedures. VIVO, which stands for View Into Ventricular Onset, enables physicians to learn more about patient specific anatomy and better help them plan the ablation procedure. |
Ra Medical Systems Announces Proposed Name and Ticker Symbol ChangesRa Medical Systems, Inc. (NYSE American:RMED) today announced that its Board of Directors has approved changing the Company's corporate name to "Catheter Precision, Inc." The effective date of the name change is expected to be August 17, 2023. |
Ra Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping System/ Ra Medical Systems, Inc. (NYSE/American:RMED) announced today that there is an increase in clinical adoption by hospitals for its VIVO system. The three-dimensional non-invasive mapping system is one of the product lines within the company's electrophysiology division, Catheter Precision, LLC. |
RMED's LockeT Device Utilized in Structural Heart ProceduresRa Medical Systems, Inc. (RMED:NYSE/American) today announced that its new LockeT device, used as a suture retention device for percutaneous closures, has now been utilized in structural heart procedures. |
RMED’s Electrophysiology Division Expands International DistributionRa Medical Systems, Inc. (NYSE American:RMED) has announced that it has undertaken a strong effort to expand its distribution outside of the US. Last week RMED announced it has filed for the CE Mark on LockeT, its new device to assist in closure of percutaneous puncture sites. The effort to expand international distribution reflects the anticipated timing of the receipt of the LockeT CE Mark, which is expected during this third quarter. |
RMED Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | -63.13% |
3-year | -99.81% |
5-year | -99.99% |
YTD | N/A |
2023 | 0.00% |
2022 | -92.45% |
2021 | -79.00% |
2020 | -73.70% |
2019 | -85.79% |
Loading social stream, please wait...